eGFR and Kidney Numbers: How to Read…

Estimated glomerular filtration rate, or eGFR, is one of the most visible numbers in a laboratory report. It is often treated as a verdict on kidney health. In reality, it is a model-based estimate calculated from a blood marker plus demographic variables, normalized to a standard body size, and it is useful because direct measurement of filtration is cumbersome, not because the estimate is exact.

The clinically meaningful unit is a pattern: current eGFR, previous values, urine albumin, medical context, and the decision at hand: a stable estimate of 58 over several years means something different from a fall from 95 to 58 during vomiting. A normal eGFR with substantial albuminuria can still represent important kidney disease.

What glomerular filtration rate represents#

Each kidney contains filtering units called glomeruli. GFR is the volume of plasma filtered across all functioning glomeruli per unit time. A measured GFR uses an externally administered filtration marker and timed blood or urine samples. That approach can be accurate but is too resource intensive for routine screening.

eGFR uses endogenous markers already present in blood. Creatinine is the most common. An equation translates its concentration, age, and sex into an expected filtration rate based on data from people who had measured GFR. Cystatin C provides another marker, and an equation using both can reduce errors when their non-GFR influences differ.

The reported value is usually indexed to 1.73 square meters of body-surface area. That standardization helps compare people and stage CKD; it means the number is not simply the milliliters your own kidneys filter each minute, and it is not a percentage of normal function.

Creatinine reflects production as well as clearance#

Creatinine comes from creatine metabolism in muscle and is cleared mainly through kidney filtration, with some tubular secretion. If filtration falls, blood creatinine tends to rise. The relationship is nonlinear: a small creatinine change can represent a meaningful GFR change, especially at lower concentrations.

Muscle mass affects production. A muscular athlete may have a higher creatinine than the equation expects, producing a falsely low eGFR, while a frail older adult, amputee, or person with severe muscle wasting may have a low creatinine despite impaired filtration, producing a falsely high estimate.

Cooked meat shortly before testing, creatine supplements, strenuous exercise, muscle injury, and some medicines can increase creatinine. Trimethoprim and cimetidine can reduce tubular secretion, raising creatinine without a corresponding fall in measured GFR. Laboratory and biologic variation also create small fluctuations.

Cystatin C offers a different set of limitations#

Cystatin C is produced by nucleated cells and filtered by glomeruli. It is less dependent on muscle mass and diet than creatinine. The 2021 CKD-EPI equations estimate GFR from creatinine alone, cystatin C alone, or both. On average, the combined equation is more accurate because discordant non-GFR effects can partly offset.

Cystatin C is not a pure filtration signal. Inflammation, thyroid dysfunction, glucocorticoids, smoking, obesity, and other factors can influence it. Assay availability and cost vary. A single cystatin result should still be interpreted in context.

KDIGO 2024 recommends using a combined creatinine-cystatin C estimate when creatinine alone is expected to be inaccurate and GFR affects clinical decision-making. Examples include unusual muscle mass and decisions about a medicine with a narrow therapeutic index. If both markers are unreliable or precision is especially important, measured GFR may be appropriate.

Race-free equations changed U.S. reporting#

Older U.S. eGFR equations included a coefficient for people classified as Black, producing a higher estimate at the same creatinine, age, and sex. Race is a social classification, not a direct measurement of creatinine generation or kidney function, and the coefficient could delay CKD recognition and referral.

The NKF-ASN task force recommended immediate implementation of the 2021 CKD-EPI creatinine equation without race and greater use of cystatin C. Laboratories have been transitioning, so a change in the equation can cause a visible eGFR shift even when creatinine is unchanged.

Trend review should therefore note which equation produced each of your values. Comparing a value calculated with a 2009 race coefficient to one calculated with the 2021 equation can create artificial progression or improvement. Clinical systems should label the method and avoid back-converting race categories.

One low value does not prove chronic disease#

CKD means an abnormality of kidney structure or function with implications for health that has been present for more than three months, and an eGFR below 60 mL/min/1.73 m2 can meet the filtration criterion if persistent. Markers of kidney damage, such as albuminuria, urine sediment abnormalities, structural changes, or certain biopsy findings, can establish CKD even when eGFR is 60 or higher.

An isolated low eGFR during dehydration, infection, medication change, obstruction, or another acute event may represent acute kidney injury. Previous laboratory values, repeat testing, urine output, symptoms, and the rate of change establish whether the process is acute, chronic, or acute-on-chronic.

Waiting three months is not appropriate when acute injury is suspected. A rapidly rising creatinine, very low urine output, severe swelling, breathing difficulty, dangerous potassium, or systemic illness requires prompt assessment. The chronicity definition prevents overlabeling; it does not justify delaying urgent care.

GFR categories describe severity, not the whole prognosis#

KDIGO classifies GFR as G1 at 90 or above, G2 at 60 to 89, G3a at 45 to 59, G3b at 30 to 44, G4 at 15 to 29, and G5 below 15 mL/min/1.73 m2. G1 or G2 alone does not establish CKD without another marker of kidney damage.

The boundaries help organize risk and care but do not create abrupt biological cliffs. An eGFR of 59 is not categorically different from 61 after considering uncertainty. Persistent category, trajectory, albuminuria, age, cause, and complications are more informative. At lower GFR the risks of medication accumulation, anemia, mineral and bone disorder, acidosis, hyperkalemia, and kidney failure all increase, so the timing of education and referral should follow predicted risk and clinical complexity rather than a stage label alone.

Urine albumin adds a separate axis#

The urine albumin-to-creatinine ratio, or UACR, estimates albumin loss while accounting for urine concentration. KDIGO categories are A1 below 30 mg/g, A2 from 30 to 300 mg/g, and A3 above 300 mg/g. Check the units and how your laboratory reports them.

Albuminuria can appear before eGFR falls in diabetes, hypertension, and glomerular disease. It predicts kidney progression and cardiovascular events. A person with eGFR 95 and UACR 500 has a very different risk profile from someone with the same eGFR and no albuminuria.

Exercise, fever, urinary infection, menstruation, marked hyperglycemia, and acute illness can all temporarily raise urine albumin, so confirmation with repeat first-morning samples is often appropriate unless the level and context make immediate action necessary. Persistent blood in urine or other sediment findings can point to a different process. One reading is not a diagnosis.

Trends require attention to expected variability#

Creatinine and eGFR vary with hydration, laboratory methods, diet, and ordinary biological fluctuation. A small isolated shift may not indicate progression. Repeated measurements under comparable conditions show whether there is a sustained slope.

Some kidney-protective treatments cause an early hemodynamic dip in eGFR. ACE inhibitors, angiotensin receptor blockers, and SGLT2 inhibitors reduce intraglomerular pressure, and a modest early change can accompany long-term protection. The magnitude, timing, potassium, volume status, and symptoms determine whether the response is expected or concerning.

A sudden large decline should not be dismissed as a drug effect. Volume depletion, nonsteroidal anti-inflammatory drugs, renal-artery disease, obstruction, infection, and other causes need consideration. Change your medicines with the prescriber, not from a single online threshold.

Acute kidney injury breaks steady-state assumptions#

eGFR equations assume the filtration marker is near a steady state: production and clearance are sufficiently balanced. During rapidly changing kidney function, creatinine lags behind the true GFR. Early in acute injury, eGFR can look better than actual filtration; during recovery, it can look worse.

Your laboratory may still print an eGFR during acute illness, but it should not be read as a precise stage. Clinicians use serial creatinine, urine output, hemodynamics, urinalysis, imaging, and the clinical cause.

This lag also affects medicine dosing. A value calculated from a changing creatinine can underestimate accumulation risk. Critical-care and pharmacy teams may use kinetic estimates, drug levels, or close clinical monitoring when stakes are high.

Drug dosing may need a non-indexed value#

Many labels historically used creatinine clearance estimated by the Cockcroft-Gault equation rather than CKD-EPI eGFR. Some newer labels use eGFR. The required method is product specific, and electronic systems can display several values with different units.

For unusually large or small body size, the indexed eGFR can differ from the individual's absolute filtration. Drug dosing may use a de-indexed estimate calculated from body-surface area, particularly for medicines with narrow safety margins. Using actual, ideal, or adjusted body weight in creatinine-clearance equations introduces another decision.

Pharmacists are valuable when kidney function is near a dosing boundary, changing rapidly, or estimated poorly. Do not split or stop a medicine because your portal flags a lower category.

Age changes context but not the need for evaluation#

Average GFR declines with age, and mildly reduced eGFR is common in older adults. Age affects absolute progression and mortality risk, but persistent eGFR below 60 still meets the CKD definition. The implications should be worked out for you rather than dismissed as “normal aging.”

An older person with stable G3a, no albuminuria, and few comorbidities can have a low short-term kidney-failure risk. A younger person with the same eGFR and substantial albuminuria may face a different trajectory. Risk equations such as the Kidney Failure Risk Equation can support referral and planning in applicable CKD categories.

Frailty and goals affect testing and treatment burden. They do not make medicine toxicity or acute kidney injury irrelevant. Shared decisions should separate disease labeling from the interventions likely to help.

Pregnancy and children use different interpretation#

Standard adult eGFR equations are not validated for pregnancy, where filtration changes physiologically and serum creatinine has different expected ranges. A creatinine that looks “normal” by a general laboratory flag can be concerning in pregnancy. Obstetric and nephrology context is essential.

Children use pediatric equations incorporating height and age-appropriate markers. Transition from pediatric to adult equations can create an artificial jump around the age boundary. Laboratories and clinicians should document the equation.

Dialysis is another special setting. eGFR equations are not designed to quantify residual kidney function accurately in routine dialysis care. Timed urine collections and dialysis-specific adequacy measures may be used.

A practical way to review a result#

Start with the creatinine and eGFR together, then find your prior values and the equation behind them. Ask whether you are acutely ill, dehydrated, newly taking a medicine that changes creatinine handling, or unusually muscular or frail. Review UACR and urinalysis rather than treating filtration as the only kidney signal.

If the value is unexpected, repeat testing under appropriate conditions and consider cystatin C. Evaluate blood pressure, diabetes, medicines, family history, obstruction symptoms, and systemic features. A persistent or progressive abnormality deserves a cause, not only a stage.

The right question is not “What percent are my kidneys working?” It is “How reliable is this estimate, is the change acute or chronic, what other kidney markers are present, and what decision should this number change?”

References#

Kidney results should be interpreted with prior values, urine findings, medicines, and the current clinical situation.*

Questions and answers

Is eGFR a percentage of kidney function?

No. It is an estimated filtration rate normalized to a standard body-surface area and reported in mL/min/1.73 m2. Converting it into a simple percent ignores age, equation uncertainty, body size, and kidney reserve.

Does one eGFR below 60 mean chronic kidney disease?

Not by itself. CKD requires persistent abnormal structure or function for at least three months unless prior records establish chronicity. A low value during acute illness may be acute kidney injury and can require immediate evaluation.

Why can creatinine rise after exercise or a large meat meal?

Creatinine production reflects muscle metabolism and dietary creatinine. Strenuous exercise, muscle injury, creatine supplements, and cooked meat can raise it without an equal change in filtration. Timing and trend help interpretation.

When can cystatin C help?

It can refine eGFR when muscle mass or another factor makes creatinine unreliable, or when greater accuracy would change a CKD diagnosis, medicine dose, procedure, referral, or transplant-related decision.

Why is urine albumin measured if eGFR is normal?

Albuminuria can identify kidney damage and increased cardiovascular risk before filtration falls. Combining GFR and UACR categories provides a more complete risk assessment than either result alone.